{"id":6959,"date":"2009-11-10T12:16:00","date_gmt":"2009-11-10T12:16:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/fda-panelists-at-upcoming-social-media\/"},"modified":"2019-02-21T01:22:23","modified_gmt":"2019-02-21T01:22:23","slug":"fda-panelists-at-upcoming-social-media","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/","title":{"rendered":"FDA Panelists at the Upcoming Social Media Public Hearing"},"content":{"rendered":"<p>Only the following 13 FDA panel members will be able to ask questions during this week&#8217;s public hearing on the use of social media by the pharmaceutical industry:<\/p>\n<ul>\n<li><b>Thomas W. Abrams<\/b> &#8211; Director, Division of Drug Marketing, Advertising, and Communications (DDMAC) &#8211; Center for Drug Evaluation, and Research (CDER)<\/li>\n<li><b>Kathryn J. Aikin<\/b> &#8211; Social Science Analyst, DDMAC &#8211; CDER<\/li>\n<li><b>Rachel E. Behrman<\/b> &#8211; Deputy Director, Office of Medical Policy (OMP) &#8211; CDER<\/li>\n<li><b>Gerald Dal Pan<\/b> &#8211; Director, Office of Surveillance and Epidemiology &#8211; CDER<\/li>\n<li><b>Kristin Davis<\/b> &#8211; Deputy Director, DDMAC &#8211; CDER<\/li>\n<li><b>David J. Horowitz<\/b> &#8211; Assistant Commissioner for Policy, Office of Policy, Planning, and Budget &#8211; Office of the Commissioner<\/li>\n<li><b>Ele Ibarra-Pratt<\/b> &#8211; Branch Chief, Advertising and Promotional Labeling Branch &#8211; Center for Biologics Evaluation Research<\/li>\n<li><b>Jean-Ah Kang<\/b> &#8211; Special Assistant to the Director, DDMAC &#8211; CDER<\/li>\n<li><b>Sharon Kapsch<\/b> &#8211; Chief, MDR Policy Branch &#8211; Center for Devices and Radiological Health (CDRH)<\/li>\n<li><b>Dorothy R. McAdams<\/b> &#8211; Supervisory Veterinary Medical Officer, Division of Surveillance &#8211; Center for Veterinary Medicine<\/li>\n<li><b>Seth S. Ray<\/b> &#8211; Associate Deputy Chief Counsel for Drugs and Biologics &#8211; Office of the Chief Counsel<\/li>\n<li><b>Robert Temple<\/b> &#8211; Director, OMP &#8211; CDER<\/li>\n<li><b>Deborah Wolf<\/b> &#8211; Regulatory Counsel, Office of Compliance &#8211; CDRH<\/li>\n<\/ul>\n<div class=\"separator\" style=\"clear: both; text-align: center;\"><a href=\"http:\/\/1.bp.blogspot.com\/_ZiPiXEv_Q_g\/SvlZhNnBlTI\/AAAAAAAACu0\/Ijk5tmsoaCw\/s1600-h\/slaughterhouse_29.jpg\" imageanchor=\"1\" style=\"clear: left; float: left; margin-bottom: 1em; margin-right: 1em;\"><img decoding=\"async\" border=\"0\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2009\/11\/slaughterhouse_29.jpg\" \/><\/a>\n<\/div>\n<p>This is a formidable list. Aside from Jean-Ah Kang, the only person on this list who has been featured on this blog is Robert Temple (see &#8220;<a href=\"http:\/\/pharma-mkting.com\/blog\/2007\/05\/temple-vs-nissen-blood-rematch.html\">Temple vs. Nissen: Blood Rematch<\/a>&#8220;). As one commenter to a <a href=\"http:\/\/pharmalot.com\/2007\/05\/temple_of_frustration_fda_bigg.php\">Pharmalot post<\/a> put it: &#8220;Somehow I can&#8217;t work up any empathy for Dr. Temple. His 25 years at the FDA have coincided with the deterioration of the agency.<\/p>\n<p>The FDA has organized two staging areas for speakers in order to facilitate getting on and off stage:<\/p>\n<p>(1) Reserved rows in the front left with assigned seats, and<\/p>\n<p>(2) an &#8220;On-Deck&#8221; section on stage.<\/p>\n<ol><\/ol>\n<p>&#8220;On-deck&#8221; speakers will led to the podium like cattle to slaughter! Sorry, I am in a dark mood. But I am doubtful that such a well-oiled machine will be conducive to dialogue. Perhaps some of the FDA panelists will make it to one of the &#8220;Tweetups&#8221; planned on Thursday evening (see <a href=\"http:\/\/www.fdasm.com\/\">www.fdasm.com<\/a>). That kind of interaction would be valuable.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Only the following 13 FDA panel members will be able to ask questions during this week&#8217;s public hearing on the use of social media by the pharmaceutical industry: Thomas W. Abrams &#8211; Director, Division of Drug Marketing, Advertising, and Communications (DDMAC) &#8211; Center for Drug Evaluation, and Research (CDER) Kathryn J. Aikin &#8211; Social Science [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":9652,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[44,182,167,899],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA Panelists at the Upcoming Social Media Public Hearing - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Panelists at the Upcoming Social Media Public Hearing - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Only the following 13 FDA panel members will be able to ask questions during this week&#8217;s public hearing on the use of social media by the pharmaceutical industry: Thomas W. Abrams &#8211; Director, Division of Drug Marketing, Advertising, and Communications (DDMAC) &#8211; Center for Drug Evaluation, and Research (CDER) Kathryn J. Aikin &#8211; Social Science [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2009-11-10T12:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:22:23+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2009\/11\/slaughterhouse_29.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t<meta property=\"og:image:height\" content=\"165\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/\",\"name\":\"FDA Panelists at the Upcoming Social Media Public Hearing - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2009-11-10T12:16:00+00:00\",\"dateModified\":\"2019-02-21T01:22:23+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Panelists at the Upcoming Social Media Public Hearing\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Panelists at the Upcoming Social Media Public Hearing - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/","og_locale":"en_US","og_type":"article","og_title":"FDA Panelists at the Upcoming Social Media Public Hearing - Pharma Marketing Network","og_description":"Only the following 13 FDA panel members will be able to ask questions during this week&#8217;s public hearing on the use of social media by the pharmaceutical industry: Thomas W. Abrams &#8211; Director, Division of Drug Marketing, Advertising, and Communications (DDMAC) &#8211; Center for Drug Evaluation, and Research (CDER) Kathryn J. Aikin &#8211; Social Science [&hellip;]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/","og_site_name":"Pharma Marketing Network","article_published_time":"2009-11-10T12:16:00+00:00","article_modified_time":"2019-02-21T01:22:23+00:00","og_image":[{"width":200,"height":165,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2009\/11\/slaughterhouse_29.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/","name":"FDA Panelists at the Upcoming Social Media Public Hearing - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2009-11-10T12:16:00+00:00","dateModified":"2019-02-21T01:22:23+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-panelists-at-upcoming-social-media\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"FDA Panelists at the Upcoming Social Media Public Hearing"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6959"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=6959"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6959\/revisions"}],"predecessor-version":[{"id":9653,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6959\/revisions\/9653"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/9652"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=6959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=6959"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=6959"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=6959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}